These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9744444)

  • 1. The mean ventricular fibrillation cycle length: a potentially useful parameter for programming implantable cardioverter defibrillators.
    Li H; Easley A; Windle J; Samoil D; Barrington W
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1789-94. PubMed ID: 9744444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
    Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS
    Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome].
    Binbin Y; Jingping L; Bing Y; Minglong C; Jiangang Z; Kejiang C; Qijun S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):690-4. PubMed ID: 26955725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular dysfunction is associated with prolonged average ventricular fibrillation cycle length in patients with implantable cardioverter defibrillators.
    Fenelon G; Stambler BS; Huvelle E; Brugada P; Stevenson WG;
    J Interv Card Electrophysiol; 2002 Dec; 7(3):249-54. PubMed ID: 12510136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extravascular Implantable Cardioverter-Defibrillator Sensing and Detection in a Large Global Population.
    Swerdlow C; Gillberg J; Boersma LVA; Manlucu J; Zhang X; Zhang Y; Hernandez AA; Bhatia V; Murgatroyd F
    JACC Clin Electrophysiol; 2024 Aug; 10(8):1896-1912. PubMed ID: 38752961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
    Hou CJ; Chang-Sing P; Flynn E; Martinez L; Peterson J; Ottoboni LK; Liem LB; Sung RJ
    Circulation; 1995 Nov; 92(9):2558-64. PubMed ID: 7586357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
    Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
    Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual chamber implantable cardioverter defibrillator benefits and limitations.
    Fan K; Lee K; Lau CP
    J Interv Card Electrophysiol; 1999 Oct; 3(3):239-45. PubMed ID: 10490480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms.
    Swerdlow CD; Zhou X; Voroshilovsky O; Abeyratne A; Gillberg J
    Heart Rhythm; 2008 May; 5(5):670-6. PubMed ID: 18452868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study).
    Mastenbroek MH; Pedersen SS; van der Tweel I; Doevendans PA; Meine M
    Am J Cardiol; 2016 Feb; 117(4):596-604. PubMed ID: 26732419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients.
    Hayashi Y; Takagi M; Kakihara J; Sakamoto S; Doi A; Sugioka K; Hanatani A; Yoshiyama M
    Heart Vessels; 2017 Feb; 32(2):175-185. PubMed ID: 27259484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachyarrhythmias in patients receiving an implantable cardioverter-defibrillator for primary versus secondary prophylaxis indications.
    Manuchehry A; Agusala K; Montevecchi M; Kadish A; Passman R
    Pacing Clin Electrophysiol; 2011 May; 34(5):571-6. PubMed ID: 21208242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of the fibrillation number in patients with an implantable cardioverter defibrillator.
    Hwang M; Lee H; Lee YS; Chung S; Choi SH; Shim EB; Pak HN
    Prog Biophys Mol Biol; 2014 Sep; 116(1):33-9. PubMed ID: 25236363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
    Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.